Industrial Enzyme Preparation - Acrylonitrile Hydratase Preparation

Industrial Enzyme Project: Acrylonitrile Hydratase

Project Overview & Market Potential

This project focuses on the industrial enzyme preparation of acrylonitrile hydratase, aiming to achieve domestic substitution for Japanese enzymes. The latest enzyme technology product from Japan entered the Chinese market in 2021. Currently, it is a globally monopolized product with a domestic market size of RMB 1.5 billion and a compound annual growth rate (CAGR) of 30%.

Technological Advantages & Commercial Traction

Our product has successfully passed lab-scale and pilot-scale verification, matching the performance of Japanese enzymes, and has now reached the mass production stage. We are one of only two companies globally capable of producing this product, alongside the Japanese monopoly.

Cost Advantage: Our production cost is only 20%-30% of the Japanese equivalent, granting us independent pricing power and substantial profit margins.

Market Entry: With existing contract orders of RMB 58 million, our product can rapidly integrate into clients' supply chains.

Technical Barriers: Entering this industry requires extensive accumulation in genetic engineering and fermentation engineering. Notably, genetic engineering is recognized as one of the six frontier technologies.

Financial Projections (Phase I)

Financing Requirement: RMB 20 million

Projected Output Value: RMB 150 million

Projected Gross Profit: RMB 100 million

Founder's Profile: Mi Bo

Han Ethnicity | Born: February 1977

Education

Graduated from Shandong University, majoring in Chemical Engineering and Technology.

Professional Summary

With 25 years of dedicated experience in the production management and R&D of acrylamide, Mr. Mi has been granted 13 authorized invention patents in the acrylamide industry.

Professional Experience

Zhuhai Miaohan Biotechnology Co., Ltd. | Founder & General Manager | 2023 – Present

Founded the company and currently leads a highly qualified R&D and operations team of 11 professionals, including 5 Ph.D.s, 4 Master's degree holders, and 2 Bache